Hiroshi Ohtsu

Juntendo University — Japan

Immunology and Microbiology · Life Sciences

59h-index11.7kcitations331works1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Mast cells and histamine(90), Polyamine Metabolism and Applications(43), Asthma and respiratory diseases(24), COVID-19 Clinical Research Studies(20), Olfactory and Sensory Function Studies(18)

Publications328 total

Glucagon and insulin prescribing trends and cost implications in Japan: a 10-year analysis using the National Database Open Data Japan
Diabetology International·2026Open Access
Multicenter Real-World Data on First-Line Chemoimmunotherapy in Patients With Advanced Non-Small Cell Lung Cancer and Performance Status 2: WJOG18424L
Clinical Lung Cancer·2025
Abstract 4368473: Comparative Outcomes of TEVAR and Non-TEVAR Management in Acute Uncomplicated Type B Aortic Dissection: Age-Stratified Analysis Using a Claims Database Including the Elderly in Japan
Circulation·2025
Comparative analysis of the tumor immune microenvironment between thymoma and thymic carcinoma
Lung Cancer·2025
Long-term outcomes of initial thoracic endovascular repair versus medical therapy in acute uncomplicated type B aortic dissection: real-world evidence from a nationwide claims database in Japan – a retrospective cohort study
BMJ Surgery Interventions & Health Technologies·2025· 1 citedOpen Access
Breaking the One-Size-Fits-All Approach in Cardio-Oncology
JACC CardioOncology·2025· 1 citedOpen Access
Five‐Year Delivery Rate and Time to Delivery Among Women With and Without Rheumatoid Arthritis: A Real‐World Analysis Using a Nationwide Claims Database in Japan
International Journal of Rheumatic Diseases·2025Open Access
Author Correction: Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial
Nature Medicine·2025· 3 citedOpen Access
Corrigendum to ‘Impact of adjuvant trastuzumab therapy and its discontinuation on cardiac function and mortality in patients with early-stage breast cancer: An analysis based on the Japanese Receipt Claim Database’ [The Breast 79 (2025) 103871]
The Breast·2025Open Access
Impact of adjuvant trastuzumab therapy and its discontinuation on cardiac function and mortality in patients with early-stage breast cancer: An analysis based on the Japanese Receipt Claim Database
The Breast·2025· 1 citedOpen Access
Comparative Analysis of the Tumor Immune Microenvironment between Thymoma and Thymic Carcinoma
SSRN Electronic Journal·2025Open Access
Multicenter real-world data on first-line chemoimmunotherapy in patients with advanced non-small cell lung cancer and performance status 2: WJOG18424L
SSRN Electronic Journal·2025Open Access
Abstract 4137925: Long-term Outcome of Initial Thoracic Endovascular Repair or Medical Therapy in Acute Uncomplicated Type B Aortic Dissection: Real-world Data from a Nationwide Claims-Database in Japan.
Circulation·2024
Internet of things‐based approach for glycemic control in people with type 2 diabetes: A randomized controlled trial
Journal of Diabetes Investigation·2024· 2 citedOpen Access
Autologous concentrated bone marrow injection for precollapse osteonecrosis of the femoral head concurrent with contralateral total hip arthroplasty: protocol for a clinical trial
BMJ Open·2024· 1 citedOpen Access
Neuropathic pain development and maintenance and its association with motor recovery after cervical spinal cord injury
Journal of Spinal Cord Medicine·2024· 7 citedOpen Access
Time to Delivery of Women with and Without Rheumatoid Arthritis: An Analysis of Real-World Data from a Nationwide Claims Database in Japan
SSRN Electronic Journal·2024Open Access
Novel Assessment Methodology of the Reproductive Capability for Women with and Without Rheumatoid Arthritis: An Analysis of Real-World Data from a Nationwide Claims Database in Japan
SSRN Electronic Journal·2024Open Access
Comparative effectiveness of tocilizumab vs standard care in patients with severe COVID-19-related pneumonia: a retrospective cohort study utilizing registry data as a synthetic control
BMC Infectious Diseases·2023· 2 citedOpen Access
Efficacy and Safety of Treatment with Plasma from COVID-19-Recovered Individuals
Life·2023Open Access
page 1 of 17Next →

Frequent Co-authors

Takehiko Watanabe(9), Jian‐Sheng Lin(4), Noriyasu Hirasawa(4), András Nagy(4), Shunya Uchida(4), Régis Parmentier(3), Satoshi Tanaka(3), Tadashi Terui(3), Yoko Makabe‐Kobayashi(3), Eiko Sakurai(3), Kenjiro Kimura(3), Iwao Ohno(3), Yugo Shibagaki(3), Naohiko Imai(3), Satoshi Ogawa(3), Takeshi Yamashita(3), Hirotsugu Atarashi(3), Ken Okumura(3), Shiro Kamakura(3), Koichiro Kumagai(3)